| Market
The target market segments include in vitro diagnostics for
HIV and cancers, and nanoparticle therapeutics for cancers, asthma and
chronic respiratory diseases. The Global market size for these target segments
was $100 billion in 2003 and is expected to double in size within the next 10
years. This presents a very sizable opportunity for TGN products. In addition,
TGN is developing and selling custom nanoparticle reagents for various
other applications.
|
| |
|